According to research examining sexual minority patients, depression can be a consequence of health and behavioral disparities.
Kafi Friday, BA, PharmD candidate 2023; and Prashant Sakharkar, PharmD, MPH, shared their poster “Examining Health Disparities and Level of Depression among Sexual Minorities: A Population based Cross-sectional Study” at the American Pharmacists Association 2022 Annual Meeting and Exposition.
Friday and Sakharkar argued that sexual minorities, or individuals with nonheterosexual sexual orientation, face increasing challenges in achieving health equity, due to stigma and discrimination.1 In a retrospective cohort study, the investigators sought to examine health disparities and level of depression among sexual minorities; compare the prevalence of sexually transmitted infections, smoking, illicit drug use, and alcohol use in use in sexual minorities; and determine predictors of depression among sexual minorities.
The study’s results painted a grim picture for sexual minorities: sexual minorities were 3 times more likely to have gonorrhea and chlamydia infection, 65% more likely to use illicit drugs, 52% more likely to be a smoker, 3 times more likely to experience severe depression, and 2 times more likely to see a mental health clinician.
These findings suggest that depression can be a consequence of health and behavioral disparities. Screening—particularly in females who identify as a sexual minority, smoke, use illicit drugs, are under the age of 45, and are poor—might help in early intervention. Furthermore, future research should examine the association of depression, gender, and sexual minority status.
Friday K, Sakharkar P. Examining health disparities and level of depressionamong sexual minorities: A population based cross-sectional study. Presented at: American Pharmacists Association 2022 Annual Meeting & Exposition; March 18-21, 2022; San Antonio, TX